Global Swine Reproductive and Respiratory Syndrome Vaccine Market Research Report 2022

Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population.
Due to the COVID-19 pandemic, the global Swine Reproductive and Respiratory Syndrome Vaccine market size is estimated to be worth US$ 424.4 million in 2021 and is forecast to a readjusted size of US$ 844.2 million by 2028 with a CAGR of 10.2% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Swine Reproductive and Respiratory Syndrome Vaccine market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Swine Reproductive and Respiratory Syndrome Vaccine landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Boehringer ingelheim is the company with the largest market share, about 25 percent.
This report focuses on Swine Reproductive and Respiratory Syndrome Vaccine volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Swine Reproductive and Respiratory Syndrome Vaccine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, South Korea, Japan, Southeast Asia and India, etc.
Global Swine Reproductive and Respiratory Syndrome Vaccine Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Active Vaccine
Inactivated Vaccines
Segment by Application
Government Tender
Market Sales
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
ASCENT CORPORATION
Boehringer-Ingelheim
MSD Animal Health
SPAH
Ceva
Chengdu TECH-BANK Biological Products Co,.Ltd
ringpu
QILU ANIMAL HEALTH PRODUCTS CO.,LTD
DAHUANONG
CAVAC
Komipharm
Agrovet
Bioveta
JINYU BIO-TECNOLOGY CO.,LTD
Phibro Animal Health
ANHUI TIANKANG(GROUP)SHRES O., LTD
Zoetis
WINSUN BIO
PULIKE BIOLOGICAL ENGINERING,INC.

Frequently Asked Questions